Session Information

Free Paper

[FP-FR-18] AMD (or Macular Degeneration)
Go back
print
Day
Apr 04 (Fri)
Time
10:30 - 12:00
Room
Room 1 - Tokyo International Forum Hall A
Topic
Retina - Medical
Chair/Coordinator
Chair)Stephan Michels、Chair)Anat Loewenstein

Duration 5min, Q&A 3min

FP-FR-18-1 / 

Retina - Medical

Cytochrome P450 Lipid Metabolites Regulate Choroidal Neovascularization

Kip Connor

Cytochrome P450 Lipid Metabolites Regulate Choroidal Neovascularization

Duration 5min, Q&A 3min

FP-FR-18-2 / 

Retina - Medical

Diagnostic Accuracy of Multifocal Pupillographic Objective Perimetry in the Age-Related Eye Disease Study Cohort

Faran Sabeti

Diagnostic Accuracy of Multifocal Pupillographic Objective Perimetry in the Age-Related Eye Disease Study Cohort

Duration 5min, Q&A 3min

FP-FR-18-3 / 

Retina - Medical

Prevalence of Subretinal Drusenoid Deposits in Treatment of Naïve Choroidal Neovascularization in AMD

Sandrine Zweifel

Prevalence of Subretinal Drusenoid Deposits in Treatment of Naïve Choroidal Neovascularization in AMD

Duration 5min, Q&A 3min

FP-FR-18-4 / 

Retina - Medical

Uncovering the Difference Between Ranibizumab and Aflibercept in Systemic Vascular Endothelial Growth Factor Suppression in Patients with Neovascular Age-Related Macular Degeneration (UNRAVEL): Rationale and Study Design

Anat Loewenstein

Uncovering the Difference Between Ranibizumab and Aflibercept in Systemic Vascular Endothelial Growth Factor Suppression in Patients with Neovascular Age-Related Macular Degeneration (UNRAVEL): Rationale and Study Design

Duration 5min, Q&A 3min

FP-FR-18-5 / 

Retina - Medical

The SAVE-AMD trial: Safety of Vascular Endothelial Growth Factor - Antagonists in Age-related Macular Degeneration - More than Meets the Eye

Stephan Michels

The SAVE-AMD trial: Safety of Vascular Endothelial Growth Factor - Antagonists in Age-related Macular Degeneration - More than Meets the Eye

Duration 5min, Q&A 3min

FP-FR-18-6 / 

Retina - Medical

Relationship Between Large Arterial Stiffness and Typical Age-Related Macular Degeneration

Hikari Taniguchi

Relationship Between Large Arterial Stiffness and Typical Age-Related Macular Degeneration

Duration 5min, Q&A 3min

FP-FR-18-7 / 

Retina - Medical

Three-Year Results of Modified PDT Procedure (Ironing PDT) for AMD Patients with Large Lesion

Tsuyoshi Otsuji

Three-Year Results of Modified PDT Procedure (Ironing PDT) for AMD Patients with Large Lesion

Duration 5min, Q&A 3min

FP-FR-18-8 / 

Retina - Medical

Photodynamic Therapy Combined with Intravitreal Anti-Vascular Growth Factor and Dexamethasone for Treatment Resistant Neovascular Age-Related Macular Degeneration

Thomas T. Pham

Photodynamic Therapy Combined with Intravitreal Anti-Vascular Growth Factor and Dexamethasone for Treatment Resistant Neovascular Age-Related Macular Degeneration

Duration 5min, Q&A 3min

FP-FR-18-9 / 

Retina - Medical

Short Term Outcome of Saffron Supplementation in Patients with Age-Related Macular Degeneration: a Double-Blind, Placebo-Controlled, Randomized Trial

Alireza Lashay

Short Term Outcome of Saffron Supplementation in Patients with Age-Related Macular Degeneration: a Double-Blind, Placebo-Controlled, Randomized Trial

Duration 5min, Q&A 3min

FP-FR-18-10 / 

Retina - Medical

Improving Vision of Phakic or Pseudophakic Dry Type AMD Eyes by Implanting an Intra-Ocular Mirror Telescope

Isaac Lipshitz

Improving Vision of Phakic or Pseudophakic Dry Type AMD Eyes by Implanting an Intra-Ocular Mirror Telescope

Duration 5min, Q&A 3min

FP-FR-18-11 / 

Retina - Medical

Factors Predictive of Outcomes Two Years After Ranibizumab Therapy for Polypoidal Choroidal Vasculopathy

Taiichi Hikichi

Factors Predictive of Outcomes Two Years After Ranibizumab Therapy for Polypoidal Choroidal Vasculopathy

Go back